Drug intelligence / Profile preview

androsta-3,5-diene-7,17-dione

Development stage
Unknown
Lead developer
Hi-Tech Pharmaceuticals
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

**Androsta-3,5-diene-7,17-dione** (brand name: Arimistane) is a steroidal small molecule that functions as a **suicide (irreversible) aromatase inhibitor**. It is a naturally occurring metabolite of 7-Keto DHEA and does not itself convert into testosterone or estrogen. By irreversibly binding to and inactivating the aromatase enzyme (CYP19A1), it blocks the conversion of androgens (e.g., testosterone) into estrogens, thereby reducing circulating estrogen levels and secondarily elevating endogenous testosterone. It is primarily marketed as a dietary supplement by Hi-Tech Pharmaceuticals, which holds the trademark for the brand name 'Arimistane,' and is widely used in bodybuilding for post-cycle therapy (PCT) following prohormone or anabolic steroid cycles. Claimed benefits include reducing estrogen and cortisol levels, increasing testosterone, and preventing gynecomastia. The compound is banned by the World Anti-Doping Agency (WADA) and has been classified by the FDA as a prescription drug ingredient that should not be included in dietary supplements, though it continues to be sold over-the-counter.

Brand names
Arimistane
Other names
3-deoxy-7-oxo-DHEAATD
02

Targets

CYP19A1 (Aromatase)

Beyond the preview

Go deeper on androsta-3,5-diene-7,17-dione.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on androsta-3,5-diene-7,17-dione.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call